212 related articles for article (PubMed ID: 3125834)
21. [Occurrence of indirect markers of non-A, non-B hepatitis (increased anti-HBc -HBV and -ALT) in altruistic blood donors].
López Pascual J
Sangre (Barc); 1988 Feb; 33(1):58-9. PubMed ID: 3132745
[No Abstract] [Full Text] [Related]
22. Post-transfusion hepatitis B transmitted by HBsAg negative blood containing anti-HBc.
Dike AE
Med Lab Sci; 1981 Oct; 38(4):415-7. PubMed ID: 7329229
[No Abstract] [Full Text] [Related]
23. [The prevalence of hepatitis C antibodies among volunteer blood donors with elevated blood transaminase and antibodies to the B virus core antigen].
Gavilán Carrasco JC; González Santos P; Rosario Díaz E
Rev Clin Esp; 1996 May; 196(5):277-80. PubMed ID: 8768025
[TBL] [Abstract][Full Text] [Related]
24. [Screening of blood donors for the prevention of non-A, non-B hepatitis].
Seidl S
Dtsch Med Wochenschr; 1983 Jan; 108(4):123-4. PubMed ID: 6402351
[No Abstract] [Full Text] [Related]
25. [Insufficient agreement and reproducibility of 6 different enzyme immunoassays for anti-HBc--preliminary results of a study by the West German blood bank].
Caspari G; Beyer J; Elbert G; Koerner K; Muss P; Schunter F; Uy A; Gerlich W; Schmitt H
Beitr Infusionsther; 1988; 21():182-6. PubMed ID: 2462973
[No Abstract] [Full Text] [Related]
26. Prophylaxis of viral hepatitis: transfusion transmitted disease and the hepatitis B vaccine.
Holland PV
Prog Clin Biol Res; 1983; 143():357-67. PubMed ID: 6322200
[No Abstract] [Full Text] [Related]
27. [The use of a test for anti-HBc for prevention of post-transfusion hepatitis B].
Somova AV; Margolina AN; Golosova TV; Fisenko EP; Tsibinogin VV; Loseva VIa
Vopr Virusol; 1989; 34(6):749-52. PubMed ID: 2633470
[No Abstract] [Full Text] [Related]
28. Diagnostic usefulness of anti-HBc-IgM and anti-HD antibodies in acute viral hepatitis.
Esteban R; Buti M; Jardi R; Hernandez JM; Bacardi R
Gastroenterol Clin Biol; 1986 Nov; 10(11):748-51. PubMed ID: 3803810
[TBL] [Abstract][Full Text] [Related]
29. Transfusion-transmitted hepatitis virus infection.
Dodd RY
Hematol Oncol Clin North Am; 1995 Feb; 9(1):137-54. PubMed ID: 7737938
[TBL] [Abstract][Full Text] [Related]
30. [Anti-HBc and post-transfusion hepatitis B. Problems pending solution].
Acero D; Profitós J; Martí MJ; Palomer J; Caballería J; Bruguera M
Med Clin (Barc); 1984 May; 82(20):910-1. PubMed ID: 6748797
[No Abstract] [Full Text] [Related]
31. Impact of a policy to permit the return of donors repeat-reactive to the Abbott PRISM antibody to hepatitis B core antigen assay.
O'Brien SF; Yi QL; Fan W; Fearon MA; Scalia V; Goldman M
Transfusion; 2009 Feb; 49(2):271-7. PubMed ID: 19389210
[TBL] [Abstract][Full Text] [Related]
32. A review of recent events related to surrogate testing of blood to prevent non-A, non-B posttransfusion hepatitis.
Zuck TF; Sherwood WC; Bove JR
Transfusion; 1987; 27(2):203-6. PubMed ID: 3103271
[TBL] [Abstract][Full Text] [Related]
33. Antibodies to hepatitis B core antigen in blood donors screened for alanine aminotransferase level and hepatitis non-A, non-B in recipients.
Sugg U; Schenzle D; Hess G
Transfusion; 1988; 28(4):386-8. PubMed ID: 3133848
[TBL] [Abstract][Full Text] [Related]
34. Viral markers of hepatitis.
Velasco M
Lab Res Methods Biol Med; 1983; 7():103-17. PubMed ID: 6413796
[No Abstract] [Full Text] [Related]
35. Non-A, non-B hepatitis surrogate testing of blood donations.
Lancet; 1987 Jun; 1(8546):1366-7. PubMed ID: 2884466
[No Abstract] [Full Text] [Related]
36. Donor screening for hepatitis B virus infection in a cell and tissue bank.
Solves P; Mirabet V; Alvarez M; Vila E; Quiles F; Villalba JV; Montoro JA; Soler MA; Roig RJ
Transpl Infect Dis; 2008 Dec; 10(6):391-5. PubMed ID: 18665905
[TBL] [Abstract][Full Text] [Related]
37. A revised method for estimating hepatitis B virus transfusion residual risk based on antibody to hepatitis B core antigen incident cases.
Laperche S; Maniez M; Barlet V; El Ghouzzi MH; Le Vacon F; Levayer T; Lunel F; Morel P; Mouillot L; Piquet Y; Pillonel J;
Transfusion; 2008 Nov; 48(11):2308-14. PubMed ID: 18673347
[TBL] [Abstract][Full Text] [Related]
38. [Studies on hepatitis B virus infection in blood donors with positive anti-HBc and negative HBsAg].
Ren F; Li H; Zhao H
Zhonghua Yu Fang Yi Xue Za Zhi; 1998 Jan; 32(1):7-9. PubMed ID: 10322742
[TBL] [Abstract][Full Text] [Related]
39. The usefulness of surrogate markers anti-HBc and ALT for post-transfusion non-A, non-B hepatitis prevention.
Richard D
J Virol Methods; 1987 Aug; 17(1-2):105-17. PubMed ID: 3117828
[TBL] [Abstract][Full Text] [Related]
40. Markers for transfusion-associated hepatitis in north Indian blood donors: prevalence and trends.
Singh B; Verma M; Verma K
Jpn J Infect Dis; 2004 Apr; 57(2):49-51. PubMed ID: 15118208
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
